ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 973

$396K Total Retail Price of All Prescriptions

Rank: 236 out of 973

395 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 440 371 1 1
LEVOTHYROXINE SODIUM 425 366 2 2
LISINOPRIL 406 344 3 3
OMEPRAZOLE 297 226 4 5
HYDROCODONE-ACETAMINOPHEN 237 169 S3 5 4
FUROSEMIDE 231 183 6 6
GABAPENTIN 222 148 7 12
METFORMIN HCL 198 172 8 8
WARFARIN SODIUM 165 134 9 10
ALENDRONATE SODIUM 162 126 10 24
AMLODIPINE BESYLATE 151 119 11 7
POTASSIUM CHLORIDE 149 110 12 9
CITALOPRAM HBR 140 115 13 14
ATENOLOL 134 119 14 16
AZITHROMYCIN 133 91 15 47
MELOXICAM 130 110 16 23
PAROXETINE HCL 124 75 17 66
METOPROLOL TARTRATE 123 101 18 13
ALLOPURINOL 119 94 19 29
SERTRALINE HCL 115 89 20 21
DONEPEZIL HCL 115 115 20 26
ZOLPIDEM TARTRATE 114 83 22 20
LOVASTATIN 111 110 23 38
PANTOPRAZOLE SODIUM 100 76 24 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 67 25 25
ALBUTEROL SULFATE 94 94 26 137
CYCLOBENZAPRINE HCL 82 48 R 27 42
FLUTICASONE PROPIONATE 80 65 28 35
TAMSULOSIN HCL 79 75 29 28
CEPHALEXIN 75 51 30 75
PREDNISONE 74 52 31 33
CRESTOR 73 62 32 34
HYDROCHLOROTHIAZIDE 71 68 33 11
AMITRIPTYLINE HCL 70 54 R 34 52
ROPINIROLE HCL 69 55 35 72
RANITIDINE HCL 69 59 35 45
POLYETHYLENE GLYCOL 3350 69 66 35 36
CIPROFLOXACIN HCL 67 59 38 57
MORPHINE SULFATE ER 65 46 S2 39 74
ATORVASTATIN CALCIUM 60 51 40 15
FENTANYL 59 28 S2 41 53
METOPROLOL SUCCINATE 58 51 42 17
TRIAMTERENE-HYDROCHLOROTHIAZID 58 55 42 140
CLONIDINE HCL 55 42 44 67
CARVEDILOL 54 54 45 27
OXYBUTYNIN CHLORIDE 51 51 46 92
GLIMEPIRIDE 50 39 47 41
SUCRALFATE 50 45 47 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.